CPT Capital

CPT Capital is a distinguished private investment vehicle, serving as the personal investment arm of Jeremy Coller, the renowned founder of Coller Capital. Based in London, the firm is strategically focused on pioneering companies that are shaping the future of food, materials, and health. Its investment thesis is deeply rooted in supporting visionary founders who are innovating in areas such as alternative proteins, including cultivated meat, plant-based solutions, and precision fermentation technologies. CPT Capital positions itself as a long-term, patient capital provider, committed to nurturing companies from their nascent seed stages through to significant growth phases.

The firm's investment strategy is characterized by its thematic concentration and a commitment to capital-intensive sectors requiring substantial, sustained funding. CPT Capital actively seeks out opportunities where its patient capital can facilitate groundbreaking advancements and commercial scaling. Their portfolio reflects a strong bias towards companies poised to disrupt traditional industries and create sustainable alternatives. This includes significant investments in firms developing novel food production methods and bio-materials, aiming for a more sustainable and ethical future.

CPT Capital has established itself as a prominent investor in the alternative protein ecosystem, participating in some of the sector's most substantial funding rounds. For instance, the firm was a key participant in Upside Foods' Series C round, which secured an impressive $400 million, and also contributed to Mosa Meat's Series B round, raising $75 million. These examples underscore CPT Capital's capacity and willingness to deploy significant capital, often alongside other major institutional investors, to accelerate the development and market penetration of its portfolio companies. Their involvement in such large-scale rounds suggests a typical first check size that can range from a few million dollars for early-stage investments up to tens of millions for later-stage growth equity.

Through its strategic investments, CPT Capital is not merely providing capital but is actively contributing to the maturation and mainstream adoption of alternative protein and material technologies. The firm leverages its deep industry expertise and global network to support its portfolio companies in scaling operations and achieving their ambitious goals. Its commitment to these transformative sectors highlights a vision for a future where sustainable and innovative solutions address pressing global challenges in food security and resource management.